 Athenex, Inc. is a biopharmaceutical company developing and commercializing next-generation drugs for treating various cancers. Athenexs pipeline consists of four therapeutic programs, Orascovery P-glycoprotein pump inhibitor, Src Kinase Inhibition, Cell Therapy, and Arginine Deprivation Therapy. 